Mark Hyman, MD · 2025-05-21 · Mark Hyman (host), Joel Warsh

Doctors Debate Vaccines - Uncovering the Truth from the Noise

Health

43 claims checked against research: 4 contradicted 3 overstated 5 needing context 24 supported 1 corroborated online 6 unverified

Overstated

0:02:40 Mark Hyman (host)overstatedlow

In the 1930s and 1940s, infant teething powders containing mercury caused a syndrome that resembles autism.

"In fact, one of the things they did for teething for babies back in the '30s and '40s would give them this powder that actually they would kind of relieve some of the pain and discomfort and it was full of mercury and it caused a whole syndrome that actually looks like autism, which is crazy." (said at 0:02:40)

The speaker bundles two distinct assertions. The first assertion—that teething powders containing mercury (such as calomel) given to infants in the 1930s and 1940s caused a distinct illness—is historically well-documented as infantile acrodynia (pink disease). However, the second assertion—that this syndrome 'looks like autism'—is overstated. Infantile acrodynia is a toxic and hypersensitivity reaction characterized primarily by pink, painful, desquamating hands and feet, photophobia, hypertension, profuse sweating, and extreme irritability, which does not clinically resemble autism spectrum disorder (characterized by deficits in social communication and restricted, repetitive behaviors), despite speculative hypotheses attempting to link mercury toxicity to autism.

context: Ancestry of pink disease (infantile acrodynia) identified as a risk factor for autism spec… (Journal of toxicology and environmental health. Part A 2011) · cited 40x in the literature
"Pink disease (infantile acrodynia) was especially prevalent in the first half of the 20th century. Primarily attributed to exposure to mercury (Hg) commonly found in teething powders, the condition was developed by approximately 1 in 500 exposed children." (abstract, results, passage verified)
pubmed full study (doi)
context: Cutaneous manifestations of acrodynia (pink disease). (Archives of dermatology 1988) · cited 51x in the literature
"A 14-month-old girl who presented with multiple systemic complaints was found to have gingivitis, peeling of her palms and soles, and a peculiar acral eruption. A diagnosis of acrodynia, or pink disease, was confirmed by elevated levels of mercury in the urine." (abstract, results, passage verified)
pubmed
context: Mercury exposure, pink disease and Young's syndrome: a forgotten public health disaster. (BMJ case reports 2025)
"Pink disease was once a widespread phenomenon, known to physicians throughout the Western world. Its prevalence declined massively once the source, mercury, was identified in several products." (abstract, results, passage verified)
pubmed full study (doi)

0:28:34 Mark Hyman (host)overstatedmoderate

Cumulative mercury exposure from childhood vaccines in infants prior to the 2000 phase-out exceeded the EPA safe exposure limit by approximately 162 times.

"And by the way, for a kid, it's about 162 times the amount of mercury that the EPA says is safe to have in a baby, right? And then quietly around 2000, they took it out of most vaccines except the multi-dose flu vaccine and a few other vaccines." (said at 0:28:34)

Prior to the 1999–2001 phase-out of thimerosal from routine childhood vaccines in the United States, FDA risk assessments evaluated cumulative infant ethylmercury exposure from the recommended schedule (up to 187.5 µg of mercury over the first 6 months of life). Depending on body weight and specific vaccine formulation, cumulative exposure during the first 6 months could marginally exceed the Environmental Protection Agency (EPA) chronic oral reference dose for methylmercury (0.1 µg/kg/day), but by modest amounts (averaging around 0.1 to 0.2 µg/kg/day across 180 days), not 162 times. The figure of ~162 times is derived from misapplying the EPA's chronic, daily, lifetime oral ingestion limit for methylmercury to a single-day acute injection dose of ethylmercury (which is metabolized and eliminated far more rapidly), rather than calculating actual cumulative exposure or pharmacokinetics.

partial: An assessment of thimerosal use in childhood vaccines. (Pediatrics 2001) · cited 341x in the literature
"Depending on the immunization schedule, vaccine formulation, and infant weight, cumulative exposure of infants to mercury from thimerosal during the first 6 months of life may exceed EPA guidelines. Our review revealed no evidence of harm caused by doses of thimerosal in vaccines, except for local hypersensitivity reactions." (abstract, results, passage verified)
pubmed full study (doi)

0:48:40 Mark Hyman (host)overstatedmoderate

Autistic children have neuroinflammation and on MRI scans their brains are physically enlarged.

"And autism is a neuroinflammatory disease. When you look at kids' brains with autism who maybe died in a car accident, their brains are just full of inflammation. The glial cells are lit up. In fact, on MRI scans, their brains are literally larger because they're swollen." (said at 0:48:40)

The speaker conflates real findings of neuroimmune activation and early brain overgrowth with an inaccurate mechanistic claim that autistic brains are enlarged because they are 'swollen'. Postmortem neuropathological studies (such as Vargas et al., 2005) have demonstrated localized microglial and astroglial activation alongside elevated cytokines in brain tissue of individuals with autism. Furthermore, longitudinal MRI studies show that a subset of young children with autism display transient early brain overgrowth and increased cortical surface area during infancy and toddlerhood. However, autism is primarily classified as a neurodevelopmental disorder rather than a purely neuroinflammatory disease, and MRI-observed brain enlargement reflects atypical neural development and cortical expansion rather than inflammatory swelling or edema.

supports: Neuroglial activation and neuroinflammation in the brain of patients with autism. (Annals of neurology 2005) · cited 2157x in the literature
"We demonstrate an active neuroinflammatory process in the cerebral cortex, white matter, and notably in cerebellum of autistic patients. Immunocytochemical studies showed marked activation of microglia and astroglia, and cytokine profiling indicated that macrophage chemoattractant protein (MCP)-1 and tumor growth factor-beta1, derived from neuroglia, were the most prevalent cytokines in brain tissues." (abstract, results, passage verified)
pubmed full study (doi)
context: Early brain development in infants at high risk for autism spectrum disorder. (Nature 2017) · cited 1184x in the literature
"hyperexpansion of the cortical surface area between 6 and 12 months of age precedes brain volume overgrowth observed between 12 and 24 months in 15 high-risk infants who were diagnosed with autism at 24 months." (abstract, results, passage verified)
pubmed full study (doi)

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.